Literature DB >> 9416858

A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans.

K E Sullivan1, C Wooten, B J Schmeckpeper, D Goldman, M A Petri.   

Abstract

OBJECTIVE: The polymorphic tumor necrosis factor alpha (TNFalpha) gene encodes a cytokine involved in inflammation, angiogenesis, and apoptosis. One polymorphic variant is associated with increased production of TNFalpha. This study examined the frequency of this polymorphic variant in African-American patients with systemic lupus erythematosus (SLE) compared with controls.
METHODS: We determined the gene frequency of the polymorphic variant of TNFalpha in an African-American SLE patient population and in a geographically matched African-American control population.
RESULTS: The gene frequency of the TNFalpha -308A polymorphism was higher in the African-American SLE population than in the control population. This relationship was independent of major histocompatibility complex DR alleles.
CONCLUSION: The TNFalpha -308A polymorphism is associated with an increased risk of SLE in African-Americans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9416858     DOI: 10.1002/art.1780401215

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  30 in total

Review 1.  Genetics and systemic lupus erythematosus.

Authors:  B P Tsao; J M Grossman
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

Review 2.  Regulation of inflammation.

Authors:  Kathleen E Sullivan
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  Association of TNF-α promoter-308 A/G polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis.

Authors:  Hai-Feng Pan; Rui-Xue Leng; Chao Wang; Wei-Zi Qin; Li-Li Chen; Zhen-Qiu Zha; Jin-Hui Tao; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2011-04-16       Impact factor: 2.631

4.  Peripheral blood antigen-presenting cells from African-Americans exhibit increased CD80 and CD86 expression.

Authors:  A Hutchings; W M Purcell; M R Benfield
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 5.  Cytokine polymorphisms in silicosis and other pneumoconioses.

Authors:  Berran Yucesoy; Val Vallyathan; Douglas P Landsittel; Petia Simeonova; Michael I Luster
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

6.  MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus.

Authors:  N J McHugh; P Owen; B Cox; J Dunphy; K Welsh
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

Review 7.  An update on genetic studies of systemic lupus erythematosus.

Authors:  Betty P Tsao
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

Review 8.  Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.

Authors:  Antonio Brucato; Rolando Cimaz; Roberto Caporali; Véronique Ramoni; Jill Buyon
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 9.  IL-10 and TNFalpha genotypes in SLE.

Authors:  Patricia López; Carmen Gutiérrez; Ana Suárez
Journal:  J Biomed Biotechnol       Date:  2010-06-21

Review 10.  Interactions between worm infections and malaria.

Authors:  Mathieu Nacher
Journal:  Clin Rev Allergy Immunol       Date:  2004-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.